
| ASSET | DATE | % RETURN |
|---|---|---|
Safe and Green Development (SGD) | 11/13/2023 - 11/25/2023 | 602.95% |
Iterum Therapeutics (ITRM) | 11/13/2023 - 11/25/2023 | 206.67% |
Anghami (ANGH) | 11/13/2023 - 11/25/2023 | 202.15% |
Atara Biotherapeutics (ATRA) | 11/13/2023 - 11/25/2023 | 189.78% |
JIN MEDICAL INTERNATIONAL LTD Ordinary Shares (ZJYL) | 11/13/2023 - 11/25/2023 | 165.82% |
BioNexus Gene Lab Corp Common stock (BGLC) | 11/13/2023 - 11/25/2023 | 164.71% |
MoneyHero Limited Class A Ordinary Shares (MNY) | 11/13/2023 - 11/25/2023 | 155.79% |
Blackboxstocks (BLBX) | 11/13/2023 - 11/25/2023 | 137.5% |
Heron Therapeuti (HRTX) | 11/13/2023 - 11/25/2023 | 135.13% |
Scisparc (SPRC) | 11/13/2023 - 11/25/2023 | 130.73% |
Firefly Neuroscience (AIFF) | 11/13/2023 - 11/25/2023 | 128.57% |
Bakkt (BKKT) | 11/13/2023 - 11/25/2023 | 126.51% |
Ondas (ONDS) | 11/13/2023 - 11/25/2023 | 119.67% |
MIRA Pharmaceuticals, Inc Common Stock (MIRA) | 11/13/2023 - 11/25/2023 | 116.56% |
Gyre Therapeutics (GYRE) | 11/13/2023 - 11/25/2023 | 115.67% |
Direct Digital (DRCT) | 11/13/2023 - 11/25/2023 | 112.17% |
Alpha Technology Group Limited Ordinary Shares (ATGL) | 11/13/2023 - 11/25/2023 | 111.47% |
Bonk (BNKK) | 11/13/2023 - 11/25/2023 | 108.62% |
Northann (NCL) | 11/13/2023 - 11/25/2023 | 106.02% |
Ryvyl (RVYL) | 11/13/2023 - 11/25/2023 | 104.74% |
ABVC BioPharma (ABVC) | 11/13/2023 - 11/25/2023 | 94.23% |
La Rosa Holdings Corp Common Stock (LRHC) | 11/13/2023 - 11/25/2023 | 91.26% |
Jowell Global (JWEL) | 11/13/2023 - 11/25/2023 | 89.47% |
Cardio Diagnostics (CDIO) | 11/13/2023 - 11/25/2023 | 88.68% |
Wheels Up Experience (UP) | 11/13/2023 - 11/25/2023 | 77.86% |